Paper · 67171
Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) III. Immunochemical properties of the GAT-specific suppressive factor.
Theze J and 2 others. J Exp Med, 1977. Cited by 142 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) III. Immunochemical properties of the GAT-specific suppressive factor. Papers, record 67171. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/67171
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) III. Immunochemical properties of the GAT-specific suppressive factor.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunosuppression Therapy | Major topic |
| Peptides | Major topic |
| Proteins | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Epitopes | |
| Mice | |
| Mice, Inbred DBA | |
| Molecular Weight |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,084,407 | Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid50-L-tyrosine50 induced in BALB/c mice by cyclophosphamide. | J Exp Med | 1976 | https://conductscience.org/library/papers/1084407 | PubMed |
| 2 | 1,085,324 | T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells. | J Exp Med | 1976 | https://conductscience.org/library/papers/1085324 | PubMed |
| 3 | 1,085,339 | Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. IV. Special subregion assignment of the gene(s) that codes for the suppressive T-cell factor in the H-2 histocompatibility complex. | J Exp Med | 1976 | https://conductscience.org/library/papers/1085339 | PubMed |
| 4 | 1,100,764 | Antigen-specific T-cell factor in cell cooperation. Mapping within the I region of the H-2 complex and ability to cooperate across allogeneic barriers. | J Exp Med | 1975 | https://conductscience.org/library/papers/1100764 | PubMed |
| 5 | 1,101,468 | Properties of primed suppressor T cells and their products. | Transplant Rev | 1975 | https://conductscience.org/library/papers/1101468 | PubMed |
| 6 | 1,104,746 | Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice. | J Exp Med | 1975 | https://conductscience.org/library/papers/1104746 | PubMed |
| 7 | 14,097,352 | THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. | Biochem J | 1963 | https://conductscience.org/library/papers/14097352 | PubMed |
| 8 | 4,137,682 | Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT). | J Exp Med | 1974 | https://conductscience.org/library/papers/4137682 | PubMed |
| 9 | 4,610,078 | Antigen-specific T-cell factor in cell cooperation: physical properties and mapping in the left-hand (K) half of H-2. | J Exp Med | 1974 | https://conductscience.org/library/papers/4610078 | PubMed |
| 10 | 4,857,865 | Genetic control of immune responses in vitro. 3. Tolerogenic properties of the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosine10 (GAT) for spleen cells from nonresponder (H-2s and H-2q) mice. | J Exp Med | 1974 | https://conductscience.org/library/papers/4857865 | PubMed |
1 to 10 of 13
See all 13 referencesCited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 142 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,978,487 | Purification and characterization of a monoclonal T-cell suppressor factor specific for poly(LGlu60LAla30LTyr10). | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6978487 | PubMed |
| 6,966,320 | Selective suppression of the major idiotypic component of an antihapten response by soluble T cell-derived factors with idiotypic or anti-idiotypic receptors. | J Exp Med | 1980 | https://conductscience.org/library/papers/6966320 | PubMed |
| 6,800,943 | Genetic analysis of immune suppression. I. Gene complementation is required for suppression of antigen-specific proliferative responses by T-cell derived factors. | Immunogenetics | 1981 | https://conductscience.org/library/papers/6800943 | PubMed |
| 6,792,727 | Helper and suppressor T cell factors. | Springer Semin Immunopathol | 1980 | https://conductscience.org/library/papers/6792727 | PubMed |
| 6,774,046 | Two distinct antigen-specific suppressor factors induced by the oral administration of antigen. | J Exp Med | 1980 | https://conductscience.org/library/papers/6774046 | PubMed |
| 6,606,014 | Antigen-specific suppressor T cell interactions. II. Characterization of two different types of suppressor T cell factors specific for L-glutamic acid50-L-tyrosine50 (GT) and L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). | J Exp Med | 1983 | https://conductscience.org/library/papers/6606014 | PubMed |
| 6,454,757 | Haplotype-specific suppression of antibody responses in vitro. II. Suppressor factor produced by T cells and T cell hybridomas from mice treated as neonates with semiallogeneic spleen cells. | J Exp Med | 1981 | https://conductscience.org/library/papers/6454757 | PubMed |
| 6,447,186 | Suppression of antibody and T cell proliferative responses to L-glutamic acid60-L-alanine30-L-tyrosine10 by a specific monoclonal T cell factor. | J Exp Med | 1980 | https://conductscience.org/library/papers/6447186 | PubMed |
| 6,416,834 | Analysis of antibody diversity: V-D-J mRNA nucleotide sequence of four anti-GAT monoclonal antibodies. A paucigene system using alternate D-J recombinations to generate functionally similar hypervariable regions. | EMBO J | 1983 | https://conductscience.org/library/papers/6416834 | PubMed |
| 6,378,461 | Diffusible suppressor factor from splenic macrophages in murine plasmacytoma. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6378461 | PubMed |
1 to 10 of 49
See all 49 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/67171
GET https://conductscience.org/api/papers/v1/67171/cited_by?page=2